Jagsonpal Pharmaceuticals Limited secures Shareholders' Approval for Buyback

Jagsonpal Pharmaceuticals Ltd. has announced the shareholders approval for the proposal to buy-back equity shares of the Company. This marks a significant milestone in the Company's sustained efforts to enhance shareholder value.

Reinforcing its commitment to delivering long-term value to shareholders through optimised capital structure, the Board had on March 12, 2026 proposed buyback of upto 16 lakh equity shares at Rs. 250/- per equity share aggregating an amount of upto Rs. 40 Crores. The proposal was subject to shareholders approval, results of which were announced today.

The endorsement by shareholders for the proposed buyback reflects continuing investor confidence in Jagsonpal's strategic direction, financial discipline, and long-term growth prospects. The buyback is aimed at optimizing capital allocation, improving earnings per share (EPS), and delivering meaningful returns to shareholders.

The buyback is aligned with the Company's broader strategy of balancing growth investments with shareholder returns.

The way forward on the proposed buyback, including timelines and record date, will be communicated in due course in accordance with applicable regulations.

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals ShareholdersApproval Buyback